Douglas Fambrough, Chief Executive Officer at Dicerna Pharmaceuticals Inc (DRNA), sold 59,021 shares at $26.13 ($1.5M) on 2019-12-17, disclosed to the SEC on 2019-12-19.
Open-market sale of $1.5M DRNA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.13 | 56,716 | $1.5M | 96.0% |
| 2 | $26.94 | 2,305 | $62K | 4.0% |
| Total | $26.16 avg | 59,021 | $1.5M | 100% |
| Filing → |
| DRNA | SELL | 2019-12-19 | $7.2M | — | Filing → |
| DRNA | SELL | 2019-12-19 | $62K | — | Filing → |
| DRNA | SELL | 2019-12-19 | $2.0M | — | Filing → |